ADM Energy PLC

  • WKN: A2PLC1
  • ISIN: GB00BJFDXW97
  • Land: United Kingdom

Nachricht vom 26.11.2021 | 08:00

ADM Energy PLC: Notice of GM

DGAP-News: ADM Energy PLC / Key word(s): AGM/EGM
26.11.2021 / 07:00
The issuer is solely responsible for the content of this announcement.

26 November 2021

ADM Energy PLC

("ADM" or the "Company")

Posting of Circular and Notice of General Meeting

Further to the announcement of 15 November 2021, ADM Energy PLC (AIM: ADME; BER and FSE: P4JC), a natural resources investing company, announces that it will today be posting a circular to shareholders convening a General Meeting (the "Circular"), the purpose of which is to seek shareholder approval of the resolutions to be proposed at the General Meeting.

The General Meeting will be held at the offices of Shakespeare Martineau, 60 Gracechurch St, London EC3V 0HR at 11.00 a.m. GMT on 13 December 2021.

Extracts from the Circular are set out below and should be read in conjunction with the Circular. A copy of the Circular will shortly be available from the Company's website: www.admenergyplc.com


Enquiries:

ADM Energy plc +44 20 7459 4718
Osamede Okhomina, CEO  
www.admenergyplc.com  
   
Cairn Financial Advisers LLP +44 20 7213 0880
(Nominated Adviser)  
Jo Turner, James Caithie  
   
Hybridan LLP +44 20 3764 2341
(Lead Broker)  
Claire Louise Noyce  
   
ODDO BHF Corporates & Markets AG +49 69 920540
(Designated Sponsor)  
Michael B. Thiriot  
   
Luther Pendragon +44 20 7618 9100
(Financial PR)  
Harry Chathli, Alexis Gore, Tan Siddique  
 




LETTER FROM THE CHAIRMAN

Dear Shareholder

Notice of General Meeting

Introduction


On 15 November ADM Energy Plc ("Company") announced that it had raised £475,000 before expenses at a price of 1.5 pence per share. The fundraise comprised a placing of 20,000,000 new ordinary shares ("Placing Shares") to Monecor (London) Limited and a subscription for 11,666,667 new ordinary shares by certain directors. In connection with the issue of the Placing Shares, the Company, conditional upon shareholder approval, agreed to issue 6,666,667 warrants to Monecor (London) Limited to subscribe for ordinary shares at an exercise price of 3 pence per share, on a one warrant per three Placing Share basis, with an exercise period of 2 years from the date of Admission ("Warrants").

As a result of the fundraise, the Company used the majority of the share authorities available to it that were approved by shareholders at the last annual general meeting. The granting of the Warrants, therefore, is conditional on the Company obtaining approval by shareholders for renewed share authorities and, accordingly, the Company is now convening a general meeting ("GM") of shareholders to seek authority to issue the Warrants and to grant the directors additional authority to allot shares (and grant rights to subscribe for, or to convert any security into, shares in the Company) including for cash on a non-pre-emptive basis.

Resolutions

The following resolutions will be proposed at the GM:

Resolution 1

Generally, the directors may only allot shares in the Company (or grant rights to subscribe for, or to convert any security into, shares in the Company) if they have been authorised to do so by shareholders in general meeting.

Resolution 1, renews a similar authority given at this year's AGM and, if passed, will authorise the directors to allot shares in the Company (and to grant such rights) up to an aggregate amount of £2,044,808.63 (which represents the nominal amount of the Warrants to be issued and approximately 100 per cent of the issued share capital of the Company as at 26 November 2021, being the last practicable date before publication of this document). If given, this authority will expire at the conclusion of the Company's next AGM or within 15 months of the passing of Resolution 1 (whichever is the earlier). It is the directors' intention to renew the authority each year.

The directors have no current intention to exercise the authority sought under Resolution 1, except to allow for the issue of the Warrants and the grant of options, to provide additional headroom in relation to conversion rights previously granted and to ensure that the Company has maximum flexibility to raise additional capital if appropriate as and when future opportunities arise. Whilst the likelihood remains uncertain, a successful outcome may warrant the Company to make a bid deposit within a short time frame and therefore it would be impractical for the Company to apply for additional authorities at a later stage.

Resolution 2

Generally, if the directors wish to allot shares or other equity securities (within the meaning of section 560 of the Companies Act 2006 ("Act")) for cash then under the Act they must first offer such shares or securities to shareholders in proportion to their existing holdings. These statutory pre-emption rights may be disapplied by shareholders.

Resolution 2 which will be proposed as a special resolution, renews a similar, power given at this year's AGM and, if passed, will enable the directors to allot equity securities for cash without having to comply with statutory pre-emption rights.

The powers proposed under Resolution 2 will be limited to allotments:-

(a) in connection with a rights issue, open offer or other pre-emptive offer to ordinary shareholders and to holders of other equity securities (if required by the rights of those securities or the directors otherwise consider necessary), but (in accordance with normal practice) subject to such exclusions or other arrangements, such as for fractional entitlements and overseas shareholders, as the directors consider necessary;
(b) £66,666.67 in respect of the Warrants; and
(c) in any other case, up to an aggregate nominal value of £2,044,808.63 (which represents approximately 100 per cent of the issued ordinary share capital of the Company as at 26 November 2021 being the last practicable date before publication of this document).

If given, this authority will expire at the conclusion of the Company's next AGM or within 15 month of the passing of Resolution 1 (whichever is the earlier). It is the directors' intention to renew the authority each year.

The directors have no current intention to exercise the authority sought under Resolution 1, except to allow for the issue of the Warrants and options, to provide additional headroom in relation to conversion rights previously granted and to ensure that the Company has maximum flexibility to raise additional capital if future opportunities arise. In particular, the Company is in the process of trying to secure material producing assets. Whilst the likelihood remains uncertain, a successful outcome may warrant the Company to make a bid deposit within a short time frame and therefore it would be impractical for the Company to apply for additional authorities at a later stage.

Action to be taken by Shareholders

Given the current heightened risk of COVID-19 infections (and the resultant regulatory changes) which could ensure during the period in which this Notice is sent and the date of the GM and to protect our employees, local community and shareholders' welfare we are encouraging all shareholders to vote on all resolutions by appointing the chairman of the GM as their proxy. A Form of Proxy is enclosed for use at the GM. You are requested to complete, sign and return as soon as possible the Form of Proxy to the Company's Registrars, Computershare Investor Service PLC, The Pavilions, Bridgewater Road, Bristol, BS99 6ZY no later than at 11:00 a.m. on 10 December 2021. Your attention is drawn to the detailed notes to the GM and Form of Proxy.

Recommendation

The directors consider that both Resolutions that will be put to the GM will promote the success of the Company for the benefit of its shareholders as a whole. Your board will be voting in favour of the Resolutions and unanimously recommend that its shareholders vote in favour of them.

Yours faithfully

Oliver Andrews
Chairman

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.



26.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021